Ashok Kumar Yadav
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ashok Kumar Yadav has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Nabendu Debnath
Centre for Molecular Biology, Central University of Jammu Samba Jammu & Kashmir India
13 shared publicationsPooja Yadav
Centre for Molecular Biology, Central University of Jammu Samba Jammu & Kashmir India
9 shared publicationsAshwani Kumar
Department of Nutrition Biology Central University of Haryana, Jant‐Pali Mahendergarh Haryana India
6 shared publicationsAshish Tyagi
Texas A & M University
5 shared publications- Ashwani Kumar
Department of Nutrition Biology Central University of Haryana Mahendergarh Haryana India
5 shared publications Asha Chandola Saklani
School of Life Sciences, Appejay Stya University, Gurgaon, Haryana, India
4 shared publications
Latest Publications
- 21 May 2026
- Published by Wiley in Comprehensive Physiology
- Vol. 16 (3) , e70165
Dynamic Modulation of the Gut Microbiome in Neurodegenerative Diseases: Mechanisms, Therapeutic Potential, and Clinical Perspective
The gut and brain communicate bidirectionally through the gut microbiota, forming a complex network often referred to as the “microbiota–gut–brain axis.” The gastrointestinal microbiome produces various metabolites, including short‐chain fatty acids (SCFAs), tryptophan‐derived compounds, and secondary bile acids. Research indicates that disruptions in the intestinal microbiota (dysbiosis) and impaired gut–brain axis are associated with various neurological conditions. The central nervous system (CNS) influences digestive processes via the hypothalamic–pituitary–adrenal (HPA) axis and autonomic nervous system (ANS). On the other hand, the gut reciprocally affects brain function through microbial metabolites, neuroactive substances, and intestinal hormones via multiple pathways, including neural (vagal), immune, and endocrine signaling; however, only a subset of metabolites can directly access the CNS due to blood–brain barrier (BBB) selectivity. These microbial metabolites can directly or indirectly influence the CNS and modulate neuro‐immune signaling by activating receptors, such as the aryl hydrocarbon receptor (AhR) and G protein‐coupled receptors (GPCRs). By acting as ligands for these receptors, metabolites modulate neural signaling and exert neuroprotective effects. This review discusses how probiotic‐derived metabolites modulate the gut–brain axis and provide neuroprotective effects, focusing on the receptors they activate and their downstream signaling pathways involved in neuroprotection.
- 21 May 2026
- Published by Wiley in Comprehensive Physiology
- Vol. 16 (3) , e70165
Dynamic Modulation of the Gut Microbiome in Neurodegenerative Diseases: Mechanisms, Therapeutic Potential, and Clinical Perspective
The gut and brain communicate bidirectionally through the gut microbiota, forming a complex network often referred to as the “microbiota–gut–brain axis.” The gastrointestinal microbiome produces various metabolites, including short‐chain fatty acids (SCFAs), tryptophan‐derived compounds, and secondary bile acids. Research indicates that disruptions in the intestinal microbiota (dysbiosis) and impaired gut–brain axis are associated with various neurological conditions. The central nervous system (CNS) influences digestive processes via the hypothalamic–pituitary–adrenal (HPA) axis and autonomic nervous system (ANS). On the other hand, the gut reciprocally affects brain function through microbial metabolites, neuroactive substances, and intestinal hormones via multiple pathways, including neural (vagal), immune, and endocrine signaling; however, only a subset of metabolites can directly access the CNS due to blood–brain barrier (BBB) selectivity. These microbial metabolites can directly or indirectly influence the CNS and modulate neuro‐immune signaling by activating receptors, such as the aryl hydrocarbon receptor (AhR) and G protein‐coupled receptors (GPCRs). By acting as ligands for these receptors, metabolites modulate neural signaling and exert neuroprotective effects. This review discusses how probiotic‐derived metabolites modulate the gut–brain axis and provide neuroprotective effects, focusing on the receptors they activate and their downstream signaling pathways involved in neuroprotection.
- 10 April 2025
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 69 (18)
Assessment of Antimicrobial Potential of Lactiplantibacillus plantarum and Their Derived Extracellular Vesicles
Scope: Probiotic‐derived antimicrobial substances offer a promising treatment approach with less resistance risk. This study evaluated the antimicrobial activity of 20 Lactiplantibacillus plantarum strains of human gut origin and their derived extracellular vesicles (EVs) against the pathogens Staphylococcus aureus MTCC 96 and Propionibacterium acnes MTCC 1950.Methods and results: The cell‐free supernatants (CFSs) of all Lactobacillus isolates were initially screened for antimicrobial potential against the selected pathogens. The CFSs of selected isolates were further concentrated and were subjected to SDS PAGE, with bands excised for analysis of antimicrobial activity. Additionally, EVs were isolated and characterized from LpJ5 and LpJ15 and evaluated their antimicrobial activity. Results indicated that out of 20 isolates, the CFS (pH 6.5) of both the isolates demonstrated the highest zones of inhibition against S. aureus (22.9 ± 1.00 mm) and P. acnes (15.66 ± 1.52 mm), respectively. The EVs derived from LpJ5 and LpJ15 showed inhibition zones of 18.5 ± 0.2 mm and 20 ± 0.3 mm against S. aureus and P. acnes.Conclusion: Findings from this study highlight that the EVs isolated from CFS of two potent isolates LpJ5 and LpJ15, exhibit substantial antimicrobial activity, and suggest their potential application as biotherapeutic agents against selected pathogens.
- 10 April 2025
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 69 (18)
Assessment of Antimicrobial Potential of Lactiplantibacillus plantarum and Their Derived Extracellular Vesicles
Scope: Probiotic‐derived antimicrobial substances offer a promising treatment approach with less resistance risk. This study evaluated the antimicrobial activity of 20 Lactiplantibacillus plantarum strains of human gut origin and their derived extracellular vesicles (EVs) against the pathogens Staphylococcus aureus MTCC 96 and Propionibacterium acnes MTCC 1950.Methods and results: The cell‐free supernatants (CFSs) of all Lactobacillus isolates were initially screened for antimicrobial potential against the selected pathogens. The CFSs of selected isolates were further concentrated and were subjected to SDS PAGE, with bands excised for analysis of antimicrobial activity. Additionally, EVs were isolated and characterized from LpJ5 and LpJ15 and evaluated their antimicrobial activity. Results indicated that out of 20 isolates, the CFS (pH 6.5) of both the isolates demonstrated the highest zones of inhibition against S. aureus (22.9 ± 1.00 mm) and P. acnes (15.66 ± 1.52 mm), respectively. The EVs derived from LpJ5 and LpJ15 showed inhibition zones of 18.5 ± 0.2 mm and 20 ± 0.3 mm against S. aureus and P. acnes.Conclusion: Findings from this study highlight that the EVs isolated from CFS of two potent isolates LpJ5 and LpJ15, exhibit substantial antimicrobial activity, and suggest their potential application as biotherapeutic agents against selected pathogens.
- 8 April 2025
- Published by Wiley in Molecular Nutrition & Food Research
- p. e70013
Probiotic Lactobacillus‐Derived Extracellular Vesicles: Insights Into Disease Prevention and Management
Bacterial extracellular vesicles (BEVs) have emerged as versatile and promising tools for therapeutic interventions across a spectrum of medical applications. Among these, Lactobacillus‐derived extracellular vesicles (LDEVs) have garnered significant attention due to their diverse physiological functions and applications in health advancement. These LDEVs modulate host cell signaling pathways through the delivery of bioactive molecules, including nucleic acids and proteins. The immunomodulatory properties of LDEVs are important, as they have been shown to regulate the balance between pro‐inflammatory and anti‐inflammatory responses in various diseases. These LDEVs play a crucial role in maintaining gut homeostasis by modulating the composition and function of the gut microbiota, which has implications for health conditions, including inflammatory bowel diseases, metabolic disorders, and neurological disorders. Furthermore, LDEVs hold potential to deliver therapeutic payloads to specific tissues or organs. Engineered LDEVs can be loaded with therapeutic agents such as antimicrobial peptides or nucleic acid‐based therapies to treat various diseases. By leveraging the unique properties of LDEVs, researchers can develop innovative strategies for disease prevention, treatment, and overall well‐being. Thus, this review aims to provide a comprehensive overview of the therapeutic benefits of LDEVs and their implications for promoting overall well‐being.
- 8 April 2025
- Published by Wiley in Molecular Nutrition & Food Research
- p. e70013
Probiotic Lactobacillus‐Derived Extracellular Vesicles: Insights Into Disease Prevention and Management
Bacterial extracellular vesicles (BEVs) have emerged as versatile and promising tools for therapeutic interventions across a spectrum of medical applications. Among these, Lactobacillus‐derived extracellular vesicles (LDEVs) have garnered significant attention due to their diverse physiological functions and applications in health advancement. These LDEVs modulate host cell signaling pathways through the delivery of bioactive molecules, including nucleic acids and proteins. The immunomodulatory properties of LDEVs are important, as they have been shown to regulate the balance between pro‐inflammatory and anti‐inflammatory responses in various diseases. These LDEVs play a crucial role in maintaining gut homeostasis by modulating the composition and function of the gut microbiota, which has implications for health conditions, including inflammatory bowel diseases, metabolic disorders, and neurological disorders. Furthermore, LDEVs hold potential to deliver therapeutic payloads to specific tissues or organs. Engineered LDEVs can be loaded with therapeutic agents such as antimicrobial peptides or nucleic acid‐based therapies to treat various diseases. By leveraging the unique properties of LDEVs, researchers can develop innovative strategies for disease prevention, treatment, and overall well‐being. Thus, this review aims to provide a comprehensive overview of the therapeutic benefits of LDEVs and their implications for promoting overall well‐being.
- 17 November 2023
- Published by Springer Nature in Indian Journal of Microbiology
- Vol. 63 (4) , 677-692
Assessment of Probiotic and Antioxidant Potential of Indigenous Lactobacillus Strains Isolated from Human Faecal Samples
This study aimed to isolate and characterize probiotic Lactobacilli from human faecal samples of Jammu region of India and evaluation of their antioxidative properties. A total of 29 Lactobacillus strains were isolated and tested for their ability to withstand different pH levels, high concentrations of bile salt and lysozyme along with their adhesion ability to different hydrocarbons and auto-aggregation. Selected probiotic Lactobacillus isolates were further examined for their antioxidant potential using ABTS, DPPH methods, and the ability to scavenge superoxide and hydroxyl radicals. The results showed that Lactobacillus LpJ1 (7.93 ± 0.23) and LpJ5 (7.93 ± 0.59) had the highest cell viability at a pH of 2.5, while Lactobacillus LpJ16 (7.91 ± 0.48) had the highest resistance to bile salts. Many of the isolates also demonstrated good tolerance to lysozyme. The adhesion abilities of these isolates were characterized by cell surface hydrophobicity and auto aggregation which ranged between 50.32% to 77.8% and 51.02% to 78.95% respectively. In addition, Lactobacillus LpJ5 and LpJ8 showed excellent antioxidant activity. Based on these findings, the selected probiotic strains could be potential candidates for use in functional food to reduce oxidative stress. Graphical abstract
- 17 November 2023
- Published by Springer Nature in Indian Journal of Microbiology
- Vol. 63 (4) , 677-692
Assessment of Probiotic and Antioxidant Potential of Indigenous Lactobacillus Strains Isolated from Human Faecal Samples
This study aimed to isolate and characterize probiotic Lactobacilli from human faecal samples of Jammu region of India and evaluation of their antioxidative properties. A total of 29 Lactobacillus strains were isolated and tested for their ability to withstand different pH levels, high concentrations of bile salt and lysozyme along with their adhesion ability to different hydrocarbons and auto-aggregation. Selected probiotic Lactobacillus isolates were further examined for their antioxidant potential using ABTS, DPPH methods, and the ability to scavenge superoxide and hydroxyl radicals. The results showed that Lactobacillus LpJ1 (7.93 ± 0.23) and LpJ5 (7.93 ± 0.59) had the highest cell viability at a pH of 2.5, while Lactobacillus LpJ16 (7.91 ± 0.48) had the highest resistance to bile salts. Many of the isolates also demonstrated good tolerance to lysozyme. The adhesion abilities of these isolates were characterized by cell surface hydrophobicity and auto aggregation which ranged between 50.32% to 77.8% and 51.02% to 78.95% respectively. In addition, Lactobacillus LpJ5 and LpJ8 showed excellent antioxidant activity. Based on these findings, the selected probiotic strains could be potential candidates for use in functional food to reduce oxidative stress. Graphical abstract
- 26 October 2023
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 121 (1) , 100-117
Designer probiotics: Opening the new horizon in diagnosis and prevention of human diseases
Probiotic microorganisms have been used for therapeutic purposes for over a century, and recent advances in biotechnology and genetic engineering have opened up new possibilities for developing therapeutic approaches using indigenous probiotic microorganisms. Diseases are often related to metabolic and immunological factors, which play a critical role in their onset. With the help of advanced genetic tools, probiotics can be modified to produce or secrete important therapeutic peptides directly into mucosal sites, increasing their effectiveness. One potential approach to enhancing human health is through the use of designer probiotics, which possess immunogenic characteristics. These genetically engineered probiotics hold promise in providing novel therapeutic options. In addition to their immunogenic properties, designer probiotics can also be equipped with sensors and genetic circuits, enabling them to detect a range of diseases with remarkable precision. Such capabilities may significantly advance disease diagnosis and management. Furthermore, designer probiotics have the potential to be used in diagnostic applications, offering a less invasive and more cost‐effective alternative to conventional diagnostic techniques. This review offers an overview of the different functional aspects of the designer probiotics and their effectiveness on different diseases and also, we have emphasized their limitations and future implications. A comprehensive understanding of these functional attributes may pave the way for new avenues of prevention and the development of effective therapies for a range of diseases.
- 26 October 2023
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 121 (1) , 100-117
Designer probiotics: Opening the new horizon in diagnosis and prevention of human diseases
Probiotic microorganisms have been used for therapeutic purposes for over a century, and recent advances in biotechnology and genetic engineering have opened up new possibilities for developing therapeutic approaches using indigenous probiotic microorganisms. Diseases are often related to metabolic and immunological factors, which play a critical role in their onset. With the help of advanced genetic tools, probiotics can be modified to produce or secrete important therapeutic peptides directly into mucosal sites, increasing their effectiveness. One potential approach to enhancing human health is through the use of designer probiotics, which possess immunogenic characteristics. These genetically engineered probiotics hold promise in providing novel therapeutic options. In addition to their immunogenic properties, designer probiotics can also be equipped with sensors and genetic circuits, enabling them to detect a range of diseases with remarkable precision. Such capabilities may significantly advance disease diagnosis and management. Furthermore, designer probiotics have the potential to be used in diagnostic applications, offering a less invasive and more cost‐effective alternative to conventional diagnostic techniques. This review offers an overview of the different functional aspects of the designer probiotics and their effectiveness on different diseases and also, we have emphasized their limitations and future implications. A comprehensive understanding of these functional attributes may pave the way for new avenues of prevention and the development of effective therapies for a range of diseases.
- Open Access
- 4 October 2023
- Published by Wiley
Evaluation of the antimicrobial potential of indigenous probiotic strain of Lactobacillus plantarum against skin pathogens Staphylococcus aureus MTCC 96 and Propionibacterium acne MTCC 1950
In this comprehensive study, the antimicrobial activity of selected probiotic L. plantarum isolates against prevalent skin pathogens Staphylococcus aureus MTCC 96 and Propionibacterium acne MTCC 1950 were evaluated. Our findings showcased a spectrum of antimicrobial efficacy among these isolates, ranging from 10 mm ± 0.71 to 20 mm ± 0.58 against S. aureus MTCC 96 and P. acne MTCC 1950. The study delved further into the nature of antimicrobial agents by subdividing conditioned cell-free supernatants (CFS) of L. plantarum isolates into three categories. Results indicated that while 15 isolates were positive against S. aureus, only two isolates (LpJ4 and LpJ5) maintained positivity with conditioned CFS treatment. Similarly, although fourteen isolates exhibited positive results against P. acne with non-conditioned CFS, only three isolates (LpJ1, LpJ15, and LpJ19) demonstrated zone of inhibition (>14mm) with conditioned CFS. These findings emphasized the heightened antimicrobial activity of non-conditioned CFS due to the presence of organic acids. Moreover, it suggested a potential role of proteins in this antimicrobial activity, as demonstrated by the loss of inhibitory effects following treatment with proteinase K. Furthermore, our study explored the auto-aggregation and co-aggregation capabilities of these probiotic isolates, indicating their potential to adhere to gastrointestinal epithelial cells and facilitate microorganism interactions. The understanding of these factors offers substantial potential for the development of precise therapies aimed at addressing skin infections attributed to these pathogens.
- 4 October 2023
- Published by Wiley
Open AccessEvaluation of the antimicrobial potential of indigenous probiotic strain of Lactobacillus plantarum against skin pathogens Staphylococcus aureus MTCC 96 and Propionibacterium acne MTCC 1950
In this comprehensive study, the antimicrobial activity of selected probiotic L. plantarum isolates against prevalent skin pathogens Staphylococcus aureus MTCC 96 and Propionibacterium acne MTCC 1950 were evaluated. Our findings showcased a spectrum of antimicrobial efficacy among these isolates, ranging from 10 mm ± 0.71 to 20 mm ± 0.58 against S. aureus MTCC 96 and P. acne MTCC 1950. The study delved further into the nature of antimicrobial agents by subdividing conditioned cell-free supernatants (CFS) of L. plantarum isolates into three categories. Results indicated that while 15 isolates were positive against S. aureus, only two isolates (LpJ4 and LpJ5) maintained positivity with conditioned CFS treatment. Similarly, although fourteen isolates exhibited positive results against P. acne with non-conditioned CFS, only three isolates (LpJ1, LpJ15, and LpJ19) demonstrated zone of inhibition (>14mm) with conditioned CFS. These findings emphasized the heightened antimicrobial activity of non-conditioned CFS due to the presence of organic acids. Moreover, it suggested a potential role of proteins in this antimicrobial activity, as demonstrated by the loss of inhibitory effects following treatment with proteinase K. Furthermore, our study explored the auto-aggregation and co-aggregation capabilities of these probiotic isolates, indicating their potential to adhere to gastrointestinal epithelial cells and facilitate microorganism interactions. The understanding of these factors offers substantial potential for the development of precise therapies aimed at addressing skin infections attributed to these pathogens.
- 21 December 2022
- Published by Springer Nature in 3 Biotech
- Vol. 13 (1) , 1-10
Expression of heterologous heparan sulphate binding protein of Helicobacter pylori on the surface of Lactobacillus rhamnosus GG
Helicobacter pylori (H. pylori) is one of most commonly found pathogen in the stomach. In spite of emergence of different treatment strategies, H. pylori infection remains difficult to treat. The bioengineered probiotic lactobacilli that could displace H. pylori and simultaneously present immunogenic peptides such as heparan sulphate binding protein (Hsbp) to elicit immune response could emerge as a potential therapeutic agent. The aim of this study was to discover the anti-H. pylori activities and faster exclusion of H. pylori from host cells by the recombinant strain of Lactobacillus expressing the immunogenic Hsbp protein. The results were promising and showed a 65% reduction in H. pylori adhesion after two hours of pre-incubation with recombinant-LGG and HeLa S3 cells, followed by the adhesion of H. pylori pathogen (P < 0.002). Additionally, 36% and 39% reduction were examined in co-incubation and post-incubation with recombinant-LGG, respectively. When challenged with H. pylori, the proinflammatory cytokine expression was also down regulated in recombinant-LGG treated HeLa S3 cells. This promising result provides a new insight of bioengineered probiotic lactobacilli which could displace H. pylori and simultaneously has immunogenic properties thereby may be useful to prevent H. pylori infection.
- 21 December 2022
- Published by Springer Nature in 3 Biotech
- Vol. 13 (1) , 1-10
Expression of heterologous heparan sulphate binding protein of Helicobacter pylori on the surface of Lactobacillus rhamnosus GG
Helicobacter pylori (H. pylori) is one of most commonly found pathogen in the stomach. In spite of emergence of different treatment strategies, H. pylori infection remains difficult to treat. The bioengineered probiotic lactobacilli that could displace H. pylori and simultaneously present immunogenic peptides such as heparan sulphate binding protein (Hsbp) to elicit immune response could emerge as a potential therapeutic agent. The aim of this study was to discover the anti-H. pylori activities and faster exclusion of H. pylori from host cells by the recombinant strain of Lactobacillus expressing the immunogenic Hsbp protein. The results were promising and showed a 65% reduction in H. pylori adhesion after two hours of pre-incubation with recombinant-LGG and HeLa S3 cells, followed by the adhesion of H. pylori pathogen (P < 0.002). Additionally, 36% and 39% reduction were examined in co-incubation and post-incubation with recombinant-LGG, respectively. When challenged with H. pylori, the proinflammatory cytokine expression was also down regulated in recombinant-LGG treated HeLa S3 cells. This promising result provides a new insight of bioengineered probiotic lactobacilli which could displace H. pylori and simultaneously has immunogenic properties thereby may be useful to prevent H. pylori infection.
- 25 August 2022
- Published by Springer Nature
- p. 379-387
Detection of Myeloperoxidase Activity by Enzyme Linked Immunosorbent Assay
- 25 August 2022
- Published by Springer Nature
- p. 379-387
Detection of Myeloperoxidase Activity by Enzyme Linked Immunosorbent Assay
- 25 August 2022
- Published by Springer Nature
- p. 279-285
In Vivo Evaluation of Adhesion Properties of Probiotics
- 25 August 2022
- Published by Springer Nature
- p. 279-285
In Vivo Evaluation of Adhesion Properties of Probiotics